Some medications utilized in medically managed weight loss and wellness programs are considered to be used off label and may not be FDA approved for weight loss or health improvement purposes.
The major risk factors for Alzheimers disease: Age, sex, and genes modulate the microglia response to abeta plaques
Since bipolar disorder involves changes in brain chemistry and mood regulation, any medication that affects the central nervous system is worth examining more closely
This treatment offers a supportive path toward recovery based on a comprehensive assessment of individual symptoms and health history
On the cost-sensitive end, Noom offers compounded GLP-1 doses priced at $149 for the first monthwell below the $349 list price for branded 2.5mg Wegovy or Zepbound vialsa strategy it has maintained even as the FDA's shortage-based compounding exception for semaglutide wound down (May 2025)
Most patients with type 2 diabetes, as well as those with prediabetes are overweight or obese